Greece reduces VAT on pharmaceutical rebates

International Tax Review is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece reduces VAT on pharmaceutical rebates

Sponsored by

eygreece.png
Pharmaceuticals - Cover

After a long-standing debate, Greece's tax authority has reduced the VAT threshold for pharmaceutical rebates. EY Greece's Nikoletta Merkouri discusses the impact for pharmaceutical companies.

Greece’s Tax Administration acknowledged in Decision A. 1035 on February 5 2019 a reduction in the taxable amount for value added tax (VAT) for rebates granted by pharmaceutical companies to social security organisations and hospitals (Article 35, Paragraph 3 of Law 3918/2011).  

The issue has been a long-standing debate between pharmaceutical businesses and the Greek State. Under the former system, VAT corresponding to rebates was a cost suffered by the pharmaceutical businesses.

Greece’s Supreme Administrative Court has already issued decisions that determine that rebates constitute an obligatory limitation of monetary claims by pharmaceutical companies against the social security organisations, when supplying medicinal products to the latter for the benefit of the insured persons. The cost of these supplies is covered totally or partially by the social security organisation.

In simple terms, this is a reduction/discount to the original amount for the supply of the medicinal products. This is seen in Decisions 3447/2015, 3448/2015, 3449/2015 and 3450/2015, 2049/2017 and 1282/2017 of Greece’s Supreme Administrative Court.

Greece’s Tax Administration has previously accepted in Decision 1115/2016 a reduction in the taxable amount for VAT in similar situations where there is a claw-back granted by pharmaceutical companies to social security organisations (Article 11 of Law 4052/2012) and hospitals.

This is also the case of rebates granted by private pharmacies (Article 34 of Law 3918/2011) and private health services providers (Article 100 of Law 4172/2013) to social security organisations. As a result, rebates and claw-backs are now treated in a uniform manner from a VAT point of view, on account of application of the principle of equal treatment.

Consequently, the Greek Tax Administration is aligned with the judgment of the Court of Justice of the European Union (CJEU) in C-462/16 (Boehringer Ingelheim Pharma GmbH. & Co. KG), as well as in C-317/94 (Elida Gibbs), with respect to the correct interpretation and application of Article 90, Paragraph 1 of Directive 2006/112/EC (VAT Directive).

This provision embodies one of the fundamental principles of the VAT Directive, according to which the taxable amount is the consideration received, and the corollary of which is that the tax authorities may not collect an amount of VAT exceeding the tax that the taxable person received.

Finally, the CJEU has upheld that one of the principles on which the VAT system is based is neutrality. In that sense, each country with similar goods should bear the same tax burden, whatever the length of the production and distribution chain.  

The impact of this development is that pharmaceutical companies will now be able to enhance their cash position by the amount of VAT corresponding to the rebates granted to social security organisations and hospitals.

N.Merkouri - Small

Nikoletta Merkouri

This article was written by Nikoletta Merkouri of EY Greece.

Email: nikoleta.merkouri@gr.ey.com

more across site & shared bottom lb ros

More from across our site

Ascoria’s chief revenue officer shares her career wisdom garnered from the disparate worlds of tax technology, electric cables, radio DJing and more
Businesses no longer have a choice when it comes to tax technology transformation. Pavlo Boyko of TMF Group says the question is simply: sink or swim?
The firm is hunting for a senior TP manager in its quest to build a full-service practice in Indonesia, A&M Tax’s Jakarta head Jaap Zwaan tells ITR
With a new government in place, the evolving tax landscape presents both opportunities and challenges for taxpayers
Major economies have expressed concerns, with China arguing a US global minimum tax exemption would be a violation of the principle of fair competition – ITR understands
Senator Richard Colbeck told ITR he was concerned by the decision to let PwC Australia tender for government contracts again after a scandal-induced ban
Whether it be due to a fragmented advisory market or a rise in M&A, Italy’s frenetic hiring has not gone unnoticed by ITR’s Talent Tracker
The deal gives Azets 14 new partners and boosts its Swedish revenues to over $100 million; in other news, Svalner Atlas launched in Copenhagen
The tax technology company will be providing a free demonstration of its OTP software and offering best practice advice on whether to ‘buy or build’ on September 8
Johanes Glorinus Saragih of Indonesia’s Directorate General of Taxes outlines the nation’s delicate geopolitical situation, as it sits between a rock and a hard place with the US and pillar two
Gift this article